IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biomark Capital Management Co. LLC

Q2 2017 Holdings

Filed 2017-08-08 | 3 holdings | $5.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics, Inc.(ADMA)COM000899104$5.3M1,433,30499.0%
Juno Therapeutics, Inc.COM48205A109$55.7K1,864,1741.0%
Mabvax Therapeutics Holdings, Inc.COM NEW55414P504$3726,7080.0%